<DOC>
	<DOCNO>NCT01620762</DOCNO>
	<brief_summary>The purpose study compare treatment effect two treatment regimen Cat-PAD v placebo evaluate treatment effect Cat-PAD symptom , rescue medication usage Quality Life .</brief_summary>
	<brief_title>Phase III Cat-PAD Study</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>Inclusion Criteria Male female , age 1265 year . Moderate severe rhinoconjunctivitis exposure cat least 2 year . Subjects may optionally also GINA Step 1 control asthma . Positive skin prick test cat hair . Cat dander specific IgE â‰¥0.35 kU/L . Exclusion Criteria Asthma fall GINA definition `` partly control '' `` uncontrolled '' Steps 2 5 . FEV1 &lt; 80 % predict . Clinically significant confounding symptom allergy seasonal allergen final evaluation period . Skin prick test 5 mm great negative control perennial allergen animal dander ( cat ) avoid study . Significant symptoms another clinically relevant illness likely affect score rhinoconjunctivitis symptom . Clinically relevant abnormality detect physical examination . History severe drug allergy , severe angioedema anaphylactic reaction food .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Cat allergy</keyword>
	<keyword>Rhinoconjunctivitis</keyword>
</DOC>